HIV screening and PrEP; fetal tachyarrhythmia treatment in the context of AHA guidance; enlarged fetal thyroid; balloon cervical ripening after previous cesarean; low-lying placenta and hemorrhage risk; second-stage oxytocin exposure; equitable substance-use screening; and responsible clinical AI use.
Respiratory-season vaccination; ultrasound infection prevention; updated AFE management and emerging cytokine biology; adjunctive azithromycin for unscheduled cesarean delivery; prenatal CHD detection metrics; sickle cell disease; red-cell alloimmunization and fetal antigen cfDNA; FGR; sFlt-1/PlGF; and emerging preeclampsia risk-stratification evidence.
Earlier September update covering the revised SMFM pregestational diabetes checklist, updated MCDA and MCMA twin management checklists, updated aspirin risk-factor screening, penicillin-allergy assessment and testing, and emerging research on preeclampsia phenotypes.